Indications and Short-Term Outcomes for In-Office Therapeutic Superior Laryngeal Nerve Block
Annals of Otology, Rhinology & Laryngology · 2024
DOI: 10.1177/00034894231194384 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Otology, Rhinology & Laryngology, 2024. Verfasst von Alan J Gray und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of Texas Health San Antonio, San Antonio, TX, USA. Hauptthemen laut MEDLINE: Dysphonia, Larynx, Laryngeal Diseases, Airway Obstruction. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Superior laryngeal nerve (SLN) block consists of injection of steroid and anesthetic at the internal branch of the SLN entry site. Prior case series have demonstrated beneficial effects on neurogenic cough. SLN blocks have also recently shown benefit for paralaryngeal pain. We describe short-term outcomes for multiple symptoms of irritable larynx syndrome (ILS) including neurogenic cough, dysphonia related to laryngeal hypersensitivity, inducible laryngeal obstruction (ILO), paralaryngeal pain, and isolated globus.
Methods
Retrospective review from 2 institutions of patients undergoing a single SLN block for the indications listed. Variables include age, sex, indication(s), known vagus neuropathy, and patient-reported outcomes at short-term follow-up.
Results
A total of 209 patients were included (59 males, 150 females; age: 58 ± 13 years). Twenty-six patients (12%) had a history of a vagus nerve injury. Indications included neurogenic cough (n = 149), dysphonia related to laryngeal hypersensitivity (n = 66), paralaryngeal pain (n = 50), ILO (n = 23), and isolated globus (n = 3). Some patients had multiple indications. Significant improvements in patient-reported measures occurred after a single SLN block within 2 to 4 weeks for neurogenic cough (cough severity index; 25.2 ± 11.2 to 19.0 ± 12.8; P < .001), dysphonia (voice handicap index-10; 22.1 ± 12.2-18.0 ± 13.3; P = .005), and ILO (dyspnea index; 21.0 ± 14.9-14.7 ± 15.7; P = .017). Subjective pain improved in 23 of 39 patients with paralaryngeal pain. There was no observed improvement for isolated globus. Presence of known vagal neuropathy or therapy around the time of SLN block did not affect outcome.
Conclusion
SLN block can be an effective component of treatment for a variety of ILS symptoms. Patients may experience some improvement after 1 injection. Lay Summary: Symptoms of irritable larynx syndrome, such as neurogenic cough, paralaryngeal pain, inducible laryngeal obstruction, and dysphonia related to laryngeal hypersensitivity can be challenging to manage. In-office Superior Laryngeal Nerve blocks can serve as a quick, well tolerated, adjunctive treatment with positive short-term outcomes. Level of evidence: 4
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, University of Texas Health San Antonio, San Antonio, TX, USA.
- Department of Otolaryngology-Head and Neck Surgery, University of Alabama-Birmingham, Birmingham, AL, USA.
- Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, IA, USA.
- Department of Otolaryngology-Head and Neck Surgery, Cleveland Clinic Florida, Coral Springs, FL, USA.
- Department of Otolaryngology-Head and Neck Surgery, University of Texas-Southwestern, Dallas, TX, USA.
ORCID-Profile: Alan J Gray, Matthew R Hoffman, Kathleen Tibbetts
Zitieren
APA
Gray, A. J., Hoffman, M. R., Yang, Z. M., Vandiver, B., Purvis, J., Morgan, J. P., Hapner, E. R., Dominguez, L., Tibbetts, K., & Simpson, C. B. (2024). Indications and Short-Term Outcomes for In-Office Therapeutic Superior Laryngeal Nerve Block. Annals of Otology, Rhinology & Laryngology. https://doi.org/10.1177/00034894231194384
Vancouver
Gray AJ, Hoffman MR, Yang ZM, Vandiver B, Purvis J, Morgan JP, et al. Indications and Short-Term Outcomes for In-Office Therapeutic Superior Laryngeal Nerve Block. Annals of Otology, Rhinology & Laryngology. 2024. doi:10.1177/00034894231194384
BibTeX
@article{Gray2024,
author = {Gray, Alan J and Hoffman, Matthew R and Yang, Zao M and Vandiver, Beau and Purvis, Joshua and Morgan, Jake P and Hapner, Edie R and Dominguez, Laura and Tibbetts, Kathleen and Simpson, C Blake},
title = {Indications and Short-Term Outcomes for In-Office Therapeutic Superior Laryngeal Nerve Block},
journal = {Annals of Otology, Rhinology & Laryngology},
year = {2024},
doi = {10.1177/00034894231194384}
}
EUVIMED